about
Hepatic manifestations of non-steroidal inflammatory bowel disease therapyLiver injury from tumor necrosis factor-α antagonists: analysis of thirty-four casesAutoimmune-like drug-induced liver injury: a review and update for the clinician.Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Tumour necrosis factor-alpha inhibitor-induced hepatic injury in patients with rheumatoid arthritis: two case reports and an analysis of the laboratory data from the Slovenian national biologicals registry.Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 casesAutoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview.Severe cholestasis due to adalimumab in a Crohn's disease patient.Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature.Psoriasis and non-alcoholic fatty liver disease.Drug-induced autoimmune-like hepatitis.Drug-induced liver injury: a summary of recent advances.Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease.Autoimmune Hepatitis Triggered by Anti-TNF-α Therapy.Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate.Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature.
P2860
Q26773684-EFB09003-EFCE-4C64-A28F-923DB2FDAEA6Q26864098-E6361E27-C252-4132-B714-CC832333737DQ30276377-566F2800-7D44-493D-A0DF-F43B02301278Q30277969-9B84D5A2-0D18-43F1-A4F1-0A8B66A45002Q30562413-FC69B430-3745-45F5-83BD-850CFE10A6E9Q33563872-B4381038-BBC2-4A3A-B63D-90CE430EC223Q33654733-B486EF0C-CE4A-4E43-8E86-767CCDE1BA17Q35783976-DED7F041-C717-485C-A87B-BA84522802E4Q36490242-BD5590B8-EDA0-445B-9D96-C6C32AA115F8Q37266339-7891EB0D-EADA-4440-801F-16182E321DABQ37664177-DD9BD443-7BCA-4C4E-BAA7-51CE34F40236Q37788777-F753AABC-BF4B-483A-A4AD-635616DDE91EQ37843783-4BF71C55-FD7B-46F5-9692-6FB8534BE0B3Q37867695-CAE412D3-5068-40D8-BC7C-499765F0A741Q38496932-D1B85347-8C87-4825-B678-AEF59D0344B7Q38630959-79C1C4A8-ED5D-406F-8740-BCF9D454F1F4Q41256627-0B172475-5070-4248-A6BE-264DB2CAC742Q42971320-47A9359A-E5F7-4354-A683-DA02F99E3E73Q44278613-70B7ADB8-6225-48F5-8BEF-A12302153600Q48140916-6BE20373-6105-4917-B487-26AD5CE90DF0
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Adalimumab-induced autoimmune hepatitis.
@en
Adalimumab-induced autoimmune hepatitis.
@nl
type
label
Adalimumab-induced autoimmune hepatitis.
@en
Adalimumab-induced autoimmune hepatitis.
@nl
prefLabel
Adalimumab-induced autoimmune hepatitis.
@en
Adalimumab-induced autoimmune hepatitis.
@nl
P2093
P1476
Adalimumab-induced autoimmune hepatitis.
@en
P2093
Anat Scheiman-Elazary
Meir Mizrahi
Oren Shibolet
Orit Pappo
Tomer Adar
P356
10.1097/MCG.0B013E3181A745E7
P577
2010-01-01T00:00:00Z